Get Instant Summarized Text (Gist) Pharmacies excluded from Medicare Part D preferred networks are significantly more likely to close, with those not preferred by any plan facing a 3.1-fold higher ...

Pharmacies not participating as preferred pharmacies for any Part D plan were 3.1 times more likely to close, and pharmacies that were entirely out of network were 4.5 times more likely to close.

Pharmacy struggles impact ease of getting medication Pharmacy closures Longer queues, erratic hours and fewer free services What can pharmacies prescribe? How to get the medicine you need If you’re ...

Pharmacies are much more than just places to pick up prescriptions. We see this every single day with the patients we serve: Pharmacies are providing essential health care services including ...

Non-government organisations currently operate a number of community pharmacies, providing medication management consultations, a dispensing service and referrals to other healthcare resources.

HB1150 prohibits state permits to pharmacies owned by pharmacy benefit managers effective Jan. 1, 2026. Following signing of the bill into law, The National Community Pharmacists Association ...

The company’s announcement comes as many compounding pharmacies have been restricted from making unapproved, less-expensive versions of GLP-1 medications. “We felt it was really important to ...

A perfect storm of funding difficulties, staff shortages and manufacturing issues is impacting pharmacies, and as a result how easy it is to access the medication or advice you need when you need it.

B.C.’s College of Pharmacists (CPBC) says the province’s pharmacies are understaffed, a situation it says could lead to medication errors for patients, a health safety issue. “Pharmacy professionals ...

Arkansas Governor Sarah Huckabee Sanders signed a first-of-its-kind law last week preventing pharmacy benefit managers from owning or operating pharmacies, as states increasingly move to restrict ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...